Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Dusa reports positive phase III results for Levulan PDT

Oct. 24, 1997

Preclinical results with L-methioninase presented at cancer meeting

Oct. 23, 1997

Antiproliferative quinazoline derivatives disclosed at Zeneca

Oct. 23, 1997

NeoPharm moves LED to phase I for prostate cancer

Oct. 22, 1997

Pharmacyclics enters into licensing agreement with Nycomed for Lu-Tex

Oct. 21, 1997

Potential new anticancer vaccines described

Oct. 21, 1997

Yale-Vion developing bacteria-based cancer treatment

Oct. 21, 1997

Peptech reaches phase I goals for antagonist G; exercises license option

Oct. 20, 1997

ImClone and CombiChem enter alliance for drug discovery in oncology

Oct. 20, 1997

Agouron to collaborate with U.K. organizations in search for anticancer drugs

Oct. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 30, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026